Greater 0 7 0 7 O
than 8 12 8 12 O
30 13 15 13 15 B-lower_bound
% 15 16 15 16 I-lower_bound
reduction 17 26 17 26 O
in 27 29 27 29 O
wound 30 35 30 35 O
size 36 40 36 40 O
during 41 47 41 47 O
the 48 51 48 51 O
first 52 57 52 57 O
two 58 61 58 61 O
weeks 62 67 62 67 O
of 68 70 68 70 O
observation 71 82 71 82 O
and 83 86 83 86 O
treatment 87 96 87 96 B-treatment
by 97 99 97 99 O
the 100 103 100 103 O
investigator 104 116 104 116 O

Gross 0 5 117 122 O
clinical 6 14 123 131 O
infection 15 24 132 141 O
at 25 27 142 144 O
the 28 31 145 148 O
study 32 37 149 154 O
ulcer 38 43 155 160 B-chronic_disease
site 44 48 161 165 O
including 49 58 166 175 O
cellulitis 59 69 176 186 B-chronic_disease
and 70 73 187 190 O
osteomyelitis 74 87 191 204 B-chronic_disease

Hemoglobin 0 10 205 215 B-clinical_variable
of 11 13 216 218 O
less 14 18 219 223 O
than 19 23 224 228 O
10.5 24 28 229 233 B-upper_bound
g 29 30 234 235 I-upper_bound
/ 30 31 235 236 I-upper_bound
dL 31 33 236 238 I-upper_bound
Known 34 39 239 244 O
renal 40 45 245 250 O
failure 46 53 251 258 O
as 54 56 259 261 O
determined 57 67 262 272 O
by 68 70 273 275 O
a 71 72 276 277 O
Creatinine 73 83 278 288 B-clinical_variable
> 84 85 289 290 O
2.5 86 89 291 294 B-lower_bound
mg 90 92 295 297 I-lower_bound
/ 92 93 297 298 I-lower_bound
dl 93 95 298 300 I-lower_bound
Malignancy 96 106 301 311 O
at 107 109 312 314 O
or 110 112 315 317 O
near 113 117 318 322 O
the 118 121 323 326 O
ulcer 122 127 327 332 O
site 128 132 333 337 O

Known 0 5 338 343 O
allergy 6 13 344 351 O
tor 14 17 352 355 O
sensitivity 18 29 356 367 O
to 30 32 368 370 O
Eclipse 33 40 371 378 B-allergy_name
PRP 41 44 379 382 I-allergy_name
kit 45 48 383 386 I-allergy_name
components 49 59 387 397 I-allergy_name
( 60 61 398 399 O
calcium 61 68 399 406 B-allergy_name
chloride 69 77 407 415 I-allergy_name
, 77 78 415 416 O
calcium 79 86 417 424 B-allergy_name
gluconate 87 96 425 434 I-allergy_name
or 97 99 435 437 O
acid 100 104 438 442 B-allergy_name
citrate 105 112 443 450 I-allergy_name
dextrose 113 121 451 459 I-allergy_name
solution 122 130 460 468 I-allergy_name
A 131 132 469 470 I-allergy_name
( 133 134 471 472 I-allergy_name
ACDA 134 138 472 476 I-allergy_name
) 138 139 476 477 I-allergy_name
) 139 140 477 478 O

Life 0 4 479 483 B-clinical_variable
expectancy 5 15 484 494 I-clinical_variable
of 16 18 495 497 O
< 19 20 498 499 O
6 21 22 500 501 B-upper_bound
months 23 29 502 508 I-upper_bound

Medicare 0 8 509 517 O
/ 8 9 517 518 O
Medicaid 9 17 518 526 O
eligible 18 26 527 535 O
Ulcer 27 32 536 541 B-chronic_disease
of 33 35 542 544 O
pressure 36 44 545 553 O
/ 44 45 553 554 O
shear 45 50 554 559 O
etiology 51 59 560 568 O

Plasma 0 6 569 575 B-clinical_variable
Platelet 7 15 576 584 I-clinical_variable
count 16 21 585 590 I-clinical_variable
of 22 24 591 593 O
less 25 29 594 598 O
than 30 34 599 603 O
100 35 38 604 607 B-upper_bound
x 39 40 608 609 I-upper_bound
109 41 44 610 613 I-upper_bound
/ 44 45 613 614 I-upper_bound
L 45 46 614 615 I-upper_bound

Presence 0 8 616 624 O
of 9 11 625 627 O
additional 12 22 628 638 O
abnormal 23 31 639 647 O
lab 32 35 648 651 O
values 36 42 652 658 O
obtained 43 51 659 667 O
within 52 58 668 674 O
7 59 60 675 676 B-upper_bound
days 61 65 677 681 I-upper_bound
prior 66 71 682 687 I-upper_bound
to 72 74 688 690 O
the 75 78 691 694 O
Day 79 82 695 698 O
0 83 84 699 700 O
visit 85 90 701 706 O
determined 91 101 707 717 O
to 102 104 718 720 O
be 105 107 721 723 O
clinically 108 118 724 734 O
significant 119 130 735 746 O
by 131 133 747 749 O
the 134 137 750 753 O
investigator 138 150 754 766 O

Received 0 8 767 775 O
allograft 9 18 776 785 B-treatment
, 18 19 785 786 O
autograft 20 29 787 796 B-treatment
or 30 32 797 799 O
xenograft 33 42 800 809 B-treatment
within 43 49 810 816 O
30 50 52 817 819 B-upper_bound
days 53 57 820 824 I-upper_bound
of 58 60 825 827 O
enrollment 61 71 828 838 O

Received 0 8 839 847 O
another 9 16 848 855 O
investigational 17 32 856 871 O
device 33 39 872 878 O
or 40 42 879 881 O
drug 43 47 882 886 O
within 48 54 887 893 O
30 55 57 894 896 B-upper_bound
days 58 62 897 901 I-upper_bound
of 63 65 902 904 O
enrollment 66 76 905 915 O

Rheumatoid 0 10 916 926 B-chronic_disease
arthritis 11 20 927 936 I-chronic_disease
( 21 22 937 938 O
and 22 25 938 941 O
other 26 31 942 947 O
collagen 32 40 948 956 B-chronic_disease
vascular 41 49 957 965 I-chronic_disease
disease 50 57 966 973 I-chronic_disease
) 57 58 973 974 O
, 58 59 974 975 O
vasculitis 60 70 976 986 B-chronic_disease
, 70 71 986 987 O
sickle 72 78 988 994 B-chronic_disease
cell 79 83 995 999 I-chronic_disease
disease 84 91 1000 1007 I-chronic_disease
, 91 92 1007 1008 O
HIV 93 96 1009 1012 B-chronic_disease
Severe 97 103 1013 1019 O
liver 104 109 1020 1025 B-chronic_disease
disease 110 117 1026 1033 I-chronic_disease

Serum 0 5 1034 1039 B-clinical_variable
albumin 6 13 1040 1047 I-clinical_variable
of 14 16 1048 1050 O
less 17 21 1051 1055 O
than 22 26 1056 1060 O
2.5 27 30 1061 1064 B-upper_bound
g 31 32 1065 1066 I-upper_bound
/ 32 33 1066 1067 I-upper_bound
dL 33 35 1067 1069 I-upper_bound

Stage 0 5 1070 1075 B-chronic_disease
I 6 7 1076 1077 I-chronic_disease
pressure 8 16 1078 1086 I-chronic_disease
ulcers 17 23 1087 1093 I-chronic_disease
Ulcers 24 30 1094 1100 B-chronic_disease
that 31 35 1101 1105 O
are 36 39 1106 1109 O
unstageable 40 51 1110 1121 O
or 52 54 1122 1124 O
of 55 57 1125 1127 O
deep 58 62 1128 1132 O
tissue 63 69 1133 1139 O
morphology 70 80 1140 1150 O
that 81 85 1151 1155 O
have 86 90 1156 1160 O
yet 91 94 1161 1164 O
to 95 97 1165 1167 O
become 98 104 1168 1174 O
an 105 107 1175 1177 O
open 108 112 1178 1182 O
wound 113 118 1183 1188 O
Ulcer 119 124 1189 1194 O
not 125 128 1195 1198 O
of 129 131 1199 1201 O
PU 132 134 1202 1204 O
pathophysiology 135 150 1205 1220 O
( 151 152 1221 1222 O
e.g. 152 156 1222 1226 O
, 156 157 1226 1227 O
pure 158 162 1228 1232 O
diabetic 163 171 1233 1241 B-chronic_disease
, 171 172 1241 1242 O
vasculitic 173 183 1243 1253 B-chronic_disease
, 183 184 1253 1254 O
radiation 185 194 1255 1264 B-treatment
, 194 195 1264 1265 O
rheumatoid 196 206 1266 1276 B-chronic_disease
, 206 207 1276 1277 O
collagen 208 216 1278 1286 B-chronic_disease
vascular 217 225 1287 1295 I-chronic_disease
disease 226 233 1296 1303 I-chronic_disease
, 233 234 1303 1304 O
venous 235 241 1305 1311 B-chronic_disease
, 241 242 1311 1312 O
or 243 245 1313 1315 O
arterial 246 254 1316 1324 B-chronic_disease
etiology 255 263 1325 1333 I-chronic_disease
) 263 264 1333 1334 O

The 0 3 1335 1338 O
index 4 9 1339 1344 B-clinical_variable
ulcer 10 15 1345 1350 I-clinical_variable
is 16 18 1351 1353 O
greater 19 26 1354 1361 O
than 27 31 1362 1366 O
4 32 33 1367 1368 B-lower_bound
weeks 34 39 1369 1374 I-lower_bound
duration 40 48 1375 1383 O

The 0 3 1384 1387 O
largest 4 11 1388 1395 O
non 12 15 1396 1399 O
- 15 16 1399 1400 O
healing 16 23 1400 1407 O
wound 24 29 1408 1413 O
, 29 30 1413 1414 O
if 31 33 1415 1417 O
multiple 34 42 1418 1426 O
wounds 43 49 1427 1433 O
are 50 53 1434 1437 O
present 54 61 1438 1445 O
, 61 62 1445 1446 O
or 63 65 1447 1449 O
the 66 69 1450 1453 O
single 70 76 1454 1460 O
wound 77 82 1461 1466 O
to 83 85 1467 1469 O
be 86 88 1470 1472 O
treated 89 96 1473 1480 O
( 97 98 1481 1482 O
Index 98 103 1482 1487 B-clinical_variable
Ulcer 104 109 1488 1493 I-clinical_variable
) 109 110 1493 1494 O
that 111 115 1495 1499 O
is 116 118 1500 1502 O
located 119 126 1503 1510 O
on 127 129 1511 1513 O
the 130 133 1514 1517 O
heel 134 138 1518 1522 O
, 138 139 1522 1523 O
ischium 140 147 1524 1531 O
, 147 148 1531 1532 O
sacrum 149 155 1533 1539 O
, 155 156 1539 1540 O
and 157 160 1541 1544 O
trochanter 161 171 1545 1555 O
Post 172 176 1556 1560 O
- 176 177 1560 1561 O
debridement 177 188 1561 1572 O
, 188 189 1572 1573 O
the 190 193 1574 1577 O
ulcer 194 199 1578 1583 B-clinical_variable
size 200 204 1584 1588 I-clinical_variable
must 205 209 1589 1593 O
be 210 212 1594 1596 O
between 213 220 1597 1604 O
2 221 222 1605 1606 B-lower_bound
cm2 223 226 1607 1610 I-lower_bound
and 227 230 1611 1614 O
200 231 234 1615 1618 B-upper_bound
cm2 235 238 1619 1622 I-upper_bound
Demonstrated 239 251 1623 1635 O
adequate 252 260 1636 1644 O
offloading 261 271 1645 1655 O
regimen 272 279 1656 1663 O

Three 0 5 1664 1669 O
or 6 8 1670 1672 O
fewer 9 14 1673 1678 O
ulcers 15 21 1679 1685 B-chronic_disease
that 22 26 1686 1690 O
are 27 30 1691 1694 O
separated 31 40 1695 1704 O
by 41 43 1705 1707 O
> 44 45 1708 1709 O
3.0 46 49 1710 1713 B-lower_bound
cm 50 52 1714 1716 I-lower_bound
distance 53 61 1717 1725 I-lower_bound

Ulcer 0 5 1726 1731 B-chronic_disease
expected 6 14 1732 1740 O
to 15 17 1741 1743 O
be 18 20 1744 1746 O
treated 21 28 1747 1754 O
with 29 33 1755 1759 O
any 34 37 1760 1763 O
advanced 38 46 1764 1772 O
therapeutics 47 59 1773 1785 O
( 60 61 1786 1787 O
e.g. 61 65 1787 1791 O
, 65 66 1791 1792 O
HBOT 67 71 1793 1797 B-treatment
) 71 72 1797 1798 O

WBC 0 3 1799 1802 B-clinical_variable
> 4 5 1803 1804 O
13,000 5 11 1804 1810 B-lower_bound
/ 11 12 1810 1811 I-lower_bound
cm3 12 15 1811 1814 I-lower_bound
or 16 18 1815 1817 O
< 19 20 1818 1819 O
5 21 22 1820 1821 B-upper_bound
, 22 23 1821 1822 I-upper_bound
000 24 27 1823 1826 I-upper_bound
cm3 28 31 1827 1830 I-upper_bound
, 31 32 1830 1831 O
or 33 35 1832 1834 O
electrolytes 36 48 1835 1847 O
that 49 53 1848 1852 O
are 54 57 1853 1856 O
outside 58 65 1857 1864 O
the 66 69 1865 1868 O
host 70 74 1869 1873 O
institution 75 86 1874 1885 O
's 86 88 1885 1887 O
range 89 94 1888 1893 O
of 95 97 1894 1896 O
normal 98 104 1897 1903 O
Radiation 105 114 1904 1913 B-treatment
therapy 115 122 1914 1921 I-treatment
, 122 123 1921 1922 O
chemotherapy 124 136 1923 1935 B-treatment
, 136 137 1935 1936 O
immunosuppressive 138 155 1937 1954 B-treatment
therapy 156 163 1955 1962 I-treatment
or 164 166 1963 1965 O
chronic 167 174 1966 1973 B-treatment
steroid 175 182 1974 1981 I-treatment
use 183 186 1982 1985 O
within 187 193 1986 1992 O
30 194 196 1993 1995 B-upper_bound
days 197 201 1996 2000 I-upper_bound
of 202 204 2001 2003 O
enrollment 205 215 2004 2014 O

